FDA Approves TESTOSTERONE — Upsher-Smith Laboratories, LLC

Upsher-Smith Laboratories announced on September 23, 2019, that the Food and Drug Administration had approved its generic testosterone formulation for transdermal delivery, expanding the company’s portfolio in the crowded mass-market hormone therapy sector and increasing competition driving down prices in the generic testosterone market.